nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyltestosterone—SHBG—Nongenotropic Androgen signaling—GNRH1—adrenal gland cancer	0.105	0.145	CbGpPWpGaD
Methyltestosterone—Danazol—GNRHR—adrenal gland cancer	0.1	0.594	CrCbGaD
Methyltestosterone—SHBG—Nongenotropic Androgen signaling—CDC42—adrenal gland cancer	0.057	0.0785	CbGpPWpGaD
Methyltestosterone—AR—Nuclear Receptors—NR5A1—adrenal gland cancer	0.0403	0.0555	CbGpPWpGaD
Methyltestosterone—CYP19A1—Ovarian Infertility Genes—NR5A1—adrenal gland cancer	0.0398	0.0548	CbGpPWpGaD
Methyltestosterone—AR—Nongenotropic Androgen signaling—GNRH1—adrenal gland cancer	0.0325	0.0448	CbGpPWpGaD
Methyltestosterone—AR—Nuclear Receptor transcription pathway—NR5A1—adrenal gland cancer	0.0319	0.0439	CbGpPWpGaD
Methyltestosterone—SLC22A8—urine—adrenal gland cancer	0.0241	0.23	CbGeAlD
Methyltestosterone—CYP19A1—FSH signaling pathway—PRKACA—adrenal gland cancer	0.02	0.0275	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—DAXX—adrenal gland cancer	0.0177	0.0244	CbGpPWpGaD
Methyltestosterone—AR—Nongenotropic Androgen signaling—CDC42—adrenal gland cancer	0.0177	0.0243	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MED12—adrenal gland cancer	0.0134	0.0184	CbGpPWpGaD
Methyltestosterone—CYP19A1—Endogenous sterols—POMC—adrenal gland cancer	0.0124	0.0171	CbGpPWpGaD
Methyltestosterone—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.0123	0.0169	CbGpPWpGaD
Methyltestosterone—CYP3A4—urine—adrenal gland cancer	0.012	0.114	CbGeAlD
Methyltestosterone—Drospirenone—PTGS2—adrenal gland cancer	0.0116	0.0692	CrCbGaD
Methyltestosterone—Megestrol acetate—ABCB1—adrenal gland cancer	0.0113	0.0674	CrCbGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.00961	0.0132	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—adrenal gland cancer	0.0093	0.0128	CbGpPWpGaD
Methyltestosterone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—adrenal gland cancer	0.00917	0.0126	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.00893	0.0123	CbGpPWpGaD
Methyltestosterone—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00892	0.0123	CbGpPWpGaD
Methyltestosterone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.0085	0.0117	CbGpPWpGaD
Methyltestosterone—AR—Notch-mediated HES/HEY network—RB1—adrenal gland cancer	0.0079	0.0109	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—CDC42—adrenal gland cancer	0.00759	0.0104	CbGpPWpGaD
Methyltestosterone—Spironolactone—ABCB1—adrenal gland cancer	0.00705	0.0419	CrCbGaD
Methyltestosterone—Ethinyl Estradiol—ABCB1—adrenal gland cancer	0.00681	0.0405	CrCbGaD
Methyltestosterone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00672	0.00925	CbGpPWpGaD
Methyltestosterone—SHBG—gonad—adrenal gland cancer	0.00668	0.0636	CbGeAlD
Methyltestosterone—Prednisone—ABCB1—adrenal gland cancer	0.00664	0.0395	CrCbGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—adrenal gland cancer	0.00663	0.00913	CbGpPWpGaD
Methyltestosterone—ALB—Lipid and lipoprotein metabolism—PRKACA—adrenal gland cancer	0.0066	0.00909	CbGpPWpGaD
Methyltestosterone—Norethindrone—ABCB1—adrenal gland cancer	0.00655	0.0389	CrCbGaD
Methyltestosterone—SHBG—pituitary gland—adrenal gland cancer	0.00651	0.0621	CbGeAlD
Methyltestosterone—Prednisolone—ABCB1—adrenal gland cancer	0.00612	0.0364	CrCbGaD
Methyltestosterone—SHBG—adrenal gland—adrenal gland cancer	0.00582	0.0554	CbGeAlD
Methyltestosterone—AR—adrenal cortex—adrenal gland cancer	0.00579	0.0551	CbGeAlD
Methyltestosterone—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00576	0.00793	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00571	0.00786	CbGpPWpGaD
Methyltestosterone—AR—Coregulation of Androgen receptor activity—CDKN2A—adrenal gland cancer	0.00564	0.00776	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.00552	0.00759	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—NR5A1—adrenal gland cancer	0.00551	0.00758	CbGpPWpGaD
Methyltestosterone—CYP19A1—gonad—adrenal gland cancer	0.00541	0.0516	CbGeAlD
Methyltestosterone—ALB—Platelet degranulation—SPARC—adrenal gland cancer	0.00537	0.00739	CbGpPWpGaD
Methyltestosterone—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—adrenal gland cancer	0.00512	0.00704	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—CDC42—adrenal gland cancer	0.00497	0.00684	CbGpPWpGaD
Methyltestosterone—ALB—adrenal gland—adrenal gland cancer	0.00481	0.0458	CbGeAlD
Methyltestosterone—AR—gonad—adrenal gland cancer	0.00479	0.0457	CbGeAlD
Methyltestosterone—AR—cardiac atrium—adrenal gland cancer	0.00479	0.0456	CbGeAlD
Methyltestosterone—AR—Androgen receptor signaling pathway—RB1—adrenal gland cancer	0.00474	0.00652	CbGpPWpGaD
Methyltestosterone—CYP19A1—adrenal gland—adrenal gland cancer	0.00472	0.0449	CbGeAlD
Methyltestosterone—AR—Coregulation of Androgen receptor activity—CTNNB1—adrenal gland cancer	0.00472	0.00649	CbGpPWpGaD
Methyltestosterone—Hydrocortisone—ABCB1—adrenal gland cancer	0.00468	0.0278	CrCbGaD
Methyltestosterone—AR—pituitary gland—adrenal gland cancer	0.00468	0.0445	CbGeAlD
Methyltestosterone—CYP19A1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00467	0.00643	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—adrenal gland cancer	0.00454	0.00624	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—CDC42—adrenal gland cancer	0.00428	0.00589	CbGpPWpGaD
Methyltestosterone—CYP2B6—adrenal cortex—adrenal gland cancer	0.0042	0.04	CbGeAlD
Methyltestosterone—AR—adrenal gland—adrenal gland cancer	0.00418	0.0398	CbGeAlD
Methyltestosterone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00405	0.00558	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.00386	0.00532	CbGpPWpGaD
Methyltestosterone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00386	0.00531	CbGpPWpGaD
Methyltestosterone—Progesterone—ABCB1—adrenal gland cancer	0.00382	0.0227	CrCbGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—adrenal gland cancer	0.0038	0.00522	CbGpPWpGaD
Methyltestosterone—ALB—Platelet degranulation—IGF2—adrenal gland cancer	0.00371	0.0051	CbGpPWpGaD
Methyltestosterone—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.0037	0.00509	CbGpPWpGaD
Methyltestosterone—Testosterone—ABCB1—adrenal gland cancer	0.00361	0.0214	CrCbGaD
Methyltestosterone—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—adrenal gland cancer	0.00353	0.00486	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—CTNNB1—adrenal gland cancer	0.00349	0.0048	CbGpPWpGaD
Methyltestosterone—CYP2B6—gonad—adrenal gland cancer	0.00348	0.0331	CbGeAlD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—BAD—adrenal gland cancer	0.00347	0.00478	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—MED12—adrenal gland cancer	0.00331	0.00455	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—MEN1—adrenal gland cancer	0.00316	0.00435	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—BRAF—adrenal gland cancer	0.00316	0.00435	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—RB1—adrenal gland cancer	0.00311	0.00427	CbGpPWpGaD
Methyltestosterone—CYP2B6—adrenal gland—adrenal gland cancer	0.00303	0.0289	CbGeAlD
Methyltestosterone—CYP2B6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.003	0.00413	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—BAD—adrenal gland cancer	0.00299	0.00411	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.00288	0.00396	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—EGFR—adrenal gland cancer	0.00276	0.0038	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—BRAF—adrenal gland cancer	0.00272	0.00374	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—RB1—adrenal gland cancer	0.00267	0.00368	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—NR5A1—adrenal gland cancer	0.00265	0.00365	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00265	0.00364	CbGpPWpGaD
Methyltestosterone—CYP19A1—Biological oxidations—POMC—adrenal gland cancer	0.00248	0.00341	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—SDHB—adrenal gland cancer	0.00245	0.00338	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00239	0.00329	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.00238	0.00328	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	0.00228	0.00314	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00223	0.00306	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—SDHB—adrenal gland cancer	0.00222	0.00305	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.00212	0.00291	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00207	0.00285	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	0.00197	0.0027	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00193	0.00266	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.00189	0.0026	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00184	0.00253	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.00183	0.00252	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	0.00181	0.00249	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00175	0.0024	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.00171	0.00235	CbGpPWpGaD
Methyltestosterone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00168	0.00231	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00168	0.00231	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00165	0.00226	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.00164	0.00226	CbGpPWpGaD
Methyltestosterone—CYP2B6—Biological oxidations—POMC—adrenal gland cancer	0.00159	0.00219	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—MED12—adrenal gland cancer	0.00159	0.00219	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—RRM1—adrenal gland cancer	0.00158	0.00218	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—SDHD—adrenal gland cancer	0.00158	0.00218	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	0.00156	0.00214	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—MEN1—adrenal gland cancer	0.00152	0.00209	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	0.00152	0.00209	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.0015	0.00206	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00149	0.00205	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00146	0.00201	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—RRM1—adrenal gland cancer	0.00143	0.00197	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—SDHD—adrenal gland cancer	0.00143	0.00197	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—SDHB—adrenal gland cancer	0.00142	0.00196	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—TP53—adrenal gland cancer	0.00137	0.00189	CbGpPWpGaD
Methyltestosterone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00136	0.00188	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	0.00131	0.0018	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00129	0.00178	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.00126	0.00173	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—SPARC—adrenal gland cancer	0.00123	0.00169	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—SDHB—adrenal gland cancer	0.0012	0.00165	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—MED12—adrenal gland cancer	0.00118	0.00162	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—MED12—adrenal gland cancer	0.00107	0.00147	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00105	0.00145	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PRKACA—adrenal gland cancer	0.00104	0.00143	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000953	0.00131	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000944	0.0013	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—RRM1—adrenal gland cancer	0.000918	0.00126	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—SDHD—adrenal gland cancer	0.000918	0.00126	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000898	0.00123	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—CDC42—adrenal gland cancer	0.000879	0.00121	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PRKACA—adrenal gland cancer	0.00086	0.00118	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—IGF2—adrenal gland cancer	0.000848	0.00117	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000841	0.00116	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—GNAS—adrenal gland cancer	0.00084	0.00116	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PRKACA—adrenal gland cancer	0.000778	0.00107	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—SDHD—adrenal gland cancer	0.000773	0.00106	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—RRM1—adrenal gland cancer	0.000773	0.00106	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00076	0.00105	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000727	0.001	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000724	0.000996	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000714	0.000982	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—GNAS—adrenal gland cancer	0.000697	0.000959	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—MED12—adrenal gland cancer	0.000685	0.000942	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—ABCB1—adrenal gland cancer	0.000684	0.000942	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000647	0.000891	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—GNAS—adrenal gland cancer	0.00063	0.000867	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—ABCB1—adrenal gland cancer	0.000618	0.000851	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—MED12—adrenal gland cancer	0.000576	0.000793	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000515	0.000709	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PRKACA—adrenal gland cancer	0.000499	0.000687	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—POMC—adrenal gland cancer	0.00047	0.000646	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—POMC—adrenal gland cancer	0.000424	0.000584	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PRKACA—adrenal gland cancer	0.00042	0.000578	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000417	0.000574	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000417	0.000574	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000411	0.000565	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GNAS—adrenal gland cancer	0.000405	0.000557	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—ABCB1—adrenal gland cancer	0.000397	0.000546	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PTGS2—adrenal gland cancer	0.000374	0.000515	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GNAS—adrenal gland cancer	0.000341	0.000469	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PTGS2—adrenal gland cancer	0.000338	0.000466	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—ABCB1—adrenal gland cancer	0.000334	0.00046	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000311	0.000428	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—POMC—adrenal gland cancer	0.000273	0.000375	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—TP53—adrenal gland cancer	0.000269	0.00037	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—POMC—adrenal gland cancer	0.000229	0.000316	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000227	0.000312	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PTGS2—adrenal gland cancer	0.000217	0.000299	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000184	0.000253	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PTGS2—adrenal gland cancer	0.000183	0.000252	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.00018	0.000248	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—POMC—adrenal gland cancer	0.000124	0.00017	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	9.88e-05	0.000136	CbGpPWpGaD
